HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

William W Busse Selected Research

anti-IgE

6/2015Seasonal risk factors for asthma exacerbations among inner-city children.
3/2013Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents.
3/2012Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
9/2011What effect does asthma treatment have on airway remodeling? Current perspectives.
3/2011Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
10/2007Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


William W Busse Research Topics

Disease

97Asthma (Bronchial Asthma)
12/2015 - 04/2002
23Inflammation
01/2012 - 04/2002
8Infection
01/2013 - 05/2002
5Chronic Obstructive Pulmonary Disease (COPD)
09/2014 - 01/2012
5Hypersensitivity (Allergy)
03/2014 - 03/2003
5Rhinitis
05/2012 - 01/2003
3Eosinophilia
08/2009 - 04/2003
2Oral Candidiasis (Thrush)
11/2012 - 01/2012
2Anaphylaxis (Anaphylactic Shock)
05/2012 - 01/2006
2Overweight
02/2010 - 01/2010
2Seasonal Allergic Rhinitis (Hay Fever)
01/2006 - 01/2006
2Airway Obstruction (Choking)
09/2005 - 01/2003
1Respiratory Sounds (Crackle)
09/2014
1Body Weight (Weight, Body)
03/2013
1Obesity
01/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2012
1Ulcerative Colitis
10/2012
1Tremor (Tremors)
09/2012
1Nasopharyngitis
06/2010
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
04/2010
1Bronchial Spasm
11/2009
1Hyperemia
11/2009

Drug/Important Bio-Agent (IBA)

22Adrenal Cortex Hormones (Corticosteroids)IBA
11/2014 - 09/2004
13fluticasone furoateFDA Link
09/2014 - 01/2011
11Immunoglobulin E (IgE)IBA
12/2015 - 03/2003
10fluticasone (Cutivate)FDA LinkGeneric
03/2014 - 10/2004
10AntigensIBA
07/2013 - 04/2002
9Budesonide (Pulmicort)FDA LinkGeneric
01/2013 - 03/2003
8Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2015 - 02/2007
84- (2- ((6- ((2- (((2,6- dichlorophenyl)methyl)oxy)ethyl)oxy)hexyl)amino)- 1- hydroxyethyl)- 2- (hydroxymethyl)phenolIBA
09/2014 - 01/2012
7omalizumab (Xolair)FDA Link
12/2015 - 09/2004
6anti-IgEIBA
06/2015 - 10/2007
6salmeterol (Serevent)FDA Link
01/2014 - 10/2004
6CytokinesIBA
12/2011 - 11/2002
5Interleukin-5 (Interleukin 5)IBA
11/2014 - 12/2002
5AllergensIBA
09/2014 - 01/2007
5Albuterol (Salbutamol)FDA LinkGeneric
08/2010 - 03/2003
4Methacholine Chloride (Methacholine)FDA Link
08/2010 - 09/2004
4ChemokinesIBA
05/2004 - 11/2002
3Biological Markers (Surrogate Marker)IBA
12/2015 - 03/2013
3Interleukin-13IBA
07/2015 - 10/2012
3montelukast (Singulair)FDA Link
02/2010 - 01/2006
2RNA (Ribonucleic Acid)IBA
07/2015 - 01/2013
2P-SelectinIBA
07/2013 - 03/2012
2Platelet Factor 4IBA
07/2013 - 03/2012
2formoterol (Oxis)FDA Link
01/2013 - 06/2008
2Hydrocortisone (Cortisol)FDA LinkGeneric
11/2012 - 01/2012
2Superoxide DismutaseIBA
01/2011 - 08/2005
2Immunoglobulin G (IgG)IBA
11/2008 - 09/2003
2mometasone furoate (mometasone)FDA LinkGeneric
12/2005 - 08/2005
2Proteins (Proteins, Gene)IBA
08/2005 - 09/2004
2Eosinophil-Derived NeurotoxinIBA
09/2004 - 04/2003
2InterleukinsIBA
11/2003 - 06/2003
2Chemokine CCL5IBA
06/2003 - 05/2002
1DNA (Deoxyribonucleic Acid)IBA
07/2015
1Interleukin-4 (Interleukin 4)IBA
07/2015
1Monoclonal AntibodiesIBA
03/2015
1Interleukin-5 Receptors (Interleukin 5 Receptor)IBA
11/2014
1Interleukin-17 (Interleukin 27)IBA
12/2013
1fluticasone propionate - salmeterol combinationIBA
10/2013
1P-2 (P 2)IBA
08/2013
1von Willebrand FactorIBA
07/2013
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
02/2013
1Arginine (L-Arginine)FDA Link
01/2013
1Messenger RNA (mRNA)IBA
01/2013
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
12/2012
1Interleukin-1 (Interleukin 1)IBA
10/2012
1thymic stromal lymphopoietinIBA
10/2012
1HLA-DR Antigens (HLA-DR)IBA
10/2012
1Interleukin-18 ReceptorsIBA
10/2012
1HLA-DRAIBA
10/2012
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1PotassiumIBA
09/2012
1Carbon MonoxideIBA
12/2011
1GlucocorticoidsIBA
09/2011
1Dermatophagoides farinae antigen f 1IBA
04/2011
1Tryptases (Tryptase)IBA
02/2011
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2011
1AMG 317IBA
01/2011
1SmokeIBA
01/2011
1First StepIBA
09/2010
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2010
1mepolizumabIBA
04/2010
12- (cyclohexylmethylidenehydrazino)adenosineIBA
11/2009
1AdenosineFDA LinkGeneric
11/2009
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2009
1Dipyridamole (Persantine)FDA LinkGeneric
11/2009
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2009
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2009
1Human Growth Hormone (Saizen)FDA LinkGeneric
05/2009
1Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2008
1Interleukin-2 (IL2)IBA
11/2008
1daclizumab (dacliximab)FDA Link
11/2008
1EnzymesIBA
09/2008
1LipoxinsIBA
09/2008
1LeukotrienesIBA
09/2008

Therapy/Procedure

6Dry Powder Inhalers
11/2012 - 08/2005
3Immunotherapy
03/2014 - 01/2006
1Respiratory Therapy (Therapy, Respiratory)
05/2009
1Emergency Treatment
01/2009